The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Roberts Roy S since 2007.
The trader's CIK number is 1200813.
At the time of the last reporting, Roberts Roy S was the Director of Abbott Laboratories. (stock ticker symbol ABT).
Also see all insider trading activities at Abbott Laboratories.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | BNI | 0 | $0 | 9,000 | $788,337 | 9,000 | $303,255 |
| 2007 | BNI | 0 | $0 | 4,732 | $409,933 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | ABT | 0 | $0 | 34,323 | $1,549,752 | 34,323 | $1,440,399 |
| 2009 | ABT | 0 | $0 | 6,413 | $333,732 | 6,413 | $239,993 |
| 2008 | ABT | 0 | $0 | 9,427 | $534,803 | 9,427 | $329,322 |
1. Burlington Northern Santa Fe Corp (BNI)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-01-31 | BNI | Option Ex | 9,000 | 33.70 | 303,255 |
| 2008-01-31 | BNI | Sale | 9,000 | 87.59 | 788,337 |
| 2007-11-14 | BNI | Sale | 4,732 | 86.63 | 409,933 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-01-31 | ABT | Sale | 11,441 | 45.15 | 516,584 |
| 2011-01-31 | ABT | Option Ex | 11,441 | 41.97 | 480,133 |
| 2011-01-31 | ABT | Sale | 11,441 | 45.15 | 516,584 |
| 2011-01-31 | ABT | Option Ex | 11,441 | 41.97 | 480,133 |
| 2011-01-31 | ABT | Sale | 11,441 | 45.15 | 516,584 |
| 2011-01-31 | ABT | Option Ex | 11,441 | 41.97 | 480,133 |
| 2009-10-20 | ABT | Option Ex | 6,413 | 37.42 | 239,993 |
| 2009-10-20 | ABT | Sale | 6,413 | 52.04 | 333,732 |
| 2008-02-08 | ABT | Option Ex | 9,427 | 34.93 | 329,322 |
| 2008-02-08 | ABT | Sale | 9,427 | 56.73 | 534,803 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Roberts Roy S (Director of Abbott Laboratories at the time of this reporting) see the Securities and Exchange Commission (SEC) website.